Garelli V, Petitpierre N, Nicod LP. Le syndrome de chevauchement asthme-BPCO [The asthma-COPD overlap syndrome]. Rev Med Suisse. 2015 Nov 18;11(495):2145-50. French. PMID: 26742234.

Gibson P.G. McDonald V.M.

Asthma-COPD overlap 2015: now we are six.

Thorax. 2015; 70: 683-691Ray A. Camiolo M. Fitzpatrick A. et al.

Are we meeting the promise of endotypes and precision medicine in asthma?.

Physiol Rev. 2020; 100: 983-1017

Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases.

J Clin Invest. 2019; 129: 1493-1503Global Initiative for Asthma/Global Initiative for Chronic Obstructive Lung Disease

Diagnosis of diseases of chronic airflow limitation: asthma COPD and asthma-COPD overlap syndrome (ACOS) global initiative for chronic obstructive lung disease website.

(Available at:) (Accessed December 17, 2021)

Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome.

Korean J Intern Med. 2015; 30: 443-449

ACO (asthma-COPD overlap) is independent from COPD, a case in favor: a systematic review.

Diagnostics (Basel). 2021; 11: 859Lainez S. Court-Fortune I. Vercherin P. et al.

Clinical ACO phenotypes: description of a heterogeneous entity.

Respir Med Case Rep. 2019; 28: 100929Joo H. Han D. Lee J.H. et al.

Heterogeneity of asthma-COPD overlap syndrome.

Int J Chron Obstruct Pulmon Dis. 2017; 12: 697-703Toledo-Pons N. van Boven J.F.M. Román-Rodríguez M. et al.

ACO: time to move from the description of different phenotypes to the treatable traits.

PLoS One. 2019; 14: e0210915

Respiratory impedance measurements for assessment of lung mechanics: focus on asthma.

Respir Physiol Neurobiol. 2008; 163: 64-73Takeda T. Oga T. Niimi A. et al.

Relationship between small airway function and health status, dyspnea and disease control in asthma.

Respiration. 2010; 80: 120-126Mikamo M. Shirai T. Mori K. et al.

Predictors of expiratory flow limitation measured by forced oscillation technique in COPD.

BMC Pulm Med. 2014; 14: 23https://doi.org/10.1186/1471-2466-14-23Shinke H. Yamamoto M. Hazeki N. et al.

Visualized changes in respiratory resistance and reactance along a time axis in smokers: a cross-sectional study.

Respir Investig. 2013; 51: 166-174Gupta S. Siddiqui S. Haldar P. et al.

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.

Thorax. 2010; 65: 775-781Karayama M. Inui N. Yasui H. et al.

Physiological and morphological differences of airways between COPD and asthma-COPD overlap.

Sci Rep. 2019; 9: 7818Hardin M. Cho M. McDonald M.L. et al.

The clinical and genetic features of COPD-asthma overlap syndrome.

Eur Respir J. 2014; 44: 341-350Cai C. Bian X. Xue M. et al.

Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study.

Int J Chron Obstruct Pulmon Dis. 2019; 14: 1769-1778Oh J.Y. Lee Y.S. Min K.H. et al.

Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study.

Int J Chron Obstruct Pulmon Dis. 2018; 13: 1809-1818Ghosh N. Choudhury P. Kaushik S.R. et al.

Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).

Respir Res. 2020; 21: 126Sánchez Castillo S. Smith L. Díaz Suárez A. et al.

Association between physical activity and comorbidities in Spanish people with asthma-COPD overlap.

Sustainability. 2021; 13: 7580Akmatov M.K. Ermakova T. Holstiege J. et al.

Comorbidity profile of patients with concurrent diagnoses of asthma and COPD in Germany.

Sci Rep. 2020; 10: 17945Yanagisawa S. Ichinose M.

Definition and diagnosis of asthma-COPD overlap (ACO).

Allergol Int. 2018; 67: 172-178Sin D.D. Miravitlles M. Mannino D.M. et al.

What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.

Eur Respir J. 2016; 48: 664-673Pérez-de-Llano L. Cosio B.G. CHACOS study group

Asthma-COPD overlap is not a homogeneous disorder: further supporting data.

Respir Res. 2017; 18: 183Cosío B.G. Pérez de Llano L. Lopez Viña A. et al.

on behalf of the CHACOS study group. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?.

Eur Respir J. 2017; 49: 1602397Miravitlles M. Alvarez-Gutierrez F.J. Calle M. et al.

Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.

Eur Respir J. 2017; 49: 1700068Boulet L.P. Boulay M.È. Dérival J.L. et al.

Asthma-COPD overlap phenotypes and smoking: comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction.

COPD. 2018; 15: 130-138Lange P. Parner J. Vestbo J. et al.

A 15-year follow-up study of ventilatory function in adults with asthma.

N Engl J Med. 1998; 339: 1194-1200James A.L. Palmer L.J. Kicic E. et al.

Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking.

Am J Respir Crit Care Med. 2005; 171: 109-114Fabbri L.M. Caramori G. Beghe B. et al.

Physiologic consequences of long-term inflammation.

Am J Respir Crit Care Med. 1998; 157: s195-s198

Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma.

Eur Respir J. 1999; 14: 892-896Tai A. Tran H. Roberts M. et al.

The association between childhood asthma and adult chronic obstructive pulmonary disease.

Thorax. 2014; 69: 805-810Perret J.L. Dharmage S.C. Matheson M.C. et al.

The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age.

Am J Respir Crit Care Med. 2013; 187: 42-48Jamieson D.B. Matsui E.C. Belli A. et al.

Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 2013; 188: 187-192Vestbo J. Edwards L.D. Scanlon P.D. et al.

ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD.

N Engl J Med. 2011; 365: 1184-1192Putcha N. Fawzy A. Matsui E.C. et al.

Clinical phenotypes of atopy and asthma in COPD: a meta-analysis of SPIROMICS and COPDGene.

Chest. 2020; 158: 2333-2345Fattahi F. ten Hacken N.H. Löfdahl C.G. et al.

Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study.

Respir Res. 2013; 14: 10Plaza V. Álvarez F. Calle M. et al.

Consensus on the asthma-COPD overlap syndrome (ACOS) Between the Spanish COPD guidelines (GesEPOC) and the Spanish guidelines on the management of asthma (GEMA).

Arch Bronconeumol. 2017; 53: 443-449Nathan R.A. Sorkness C.A. Kosinski M. et al.

Development of the asthma control test: a survey for assessing asthma control.

J Allergy Clin Immunol. 2004; 113: 59-65Hanania N.A. Chipps B.E. Griffin N.M. et al.

Omalizumab effectiveness in asthma-COPD overlap: post hoc analysis of PROSPERO.

J Allergy Clin Immunol. 2019; 143: 1629-1633.e2Pérez de Llano L. Dacal Rivas D. Marina Malanda N. et al.

The response to biologics is better in patients with severe asthma than in patients with asthma-COPD overlap syndrome.

J Asthma Allergy. 2022; 15: 363-369Donovan T. Milan S.J. Wang R. et al.

Anti-IL-5 therapies for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2020; 12: CD013432Castro M. Corren J. Pavord I.D. et al.

Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma.

N Engl J Med. 2018; 378: 2486-2496